FIREBRICK PHARMA LTD

0.078

-0.004-4.88%

Volume:118.74K

Turnover:9.79K

Market Cap:17.52M

PE:-8.67

High:0.088

Open:0.081

Low:0.078

Close:0.082

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Firebrick Pharma Says Phase 3 Data Back Efficacy, Safety of Nasal Spray; Shares Up 25%

MT Newswires Live

·

10 Jun

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FRE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","market":"AU","secType":"STK","nameCN":"FIREBRICK PHARMA LTD","latestPrice":0.078,"timestamp":1749622320000,"preClose":0.082,"halted":0,"volume":118735,"delay":0,"nameEN":"FIREBRICK PHARMA LTD","floatShares":104130397,"shares":224576455,"eps":-0.008993,"marketStatus":"Not Yet Opened","change":-0.004,"latestTime":"06-11 16:12:00 AEST","open":0.081,"high":0.088,"low":0.078,"amount":9787,"amplitude":0.121951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.008993,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749686400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.082,"openAndCloseTimeList":[[1749600000000,1749621600000]],"volumeRatio":2.008080693274037,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRE.AU\",,,,,undefined,":{"symbol":"FRE.AU","floatShares":104130397,"roa":"-52.89%","roe":"-111.71%","lyrEps":-0.006568,"volumeRatio":2.008080693274037,"shares":224576455,"dividePrice":0,"high":0.088,"amplitude":0.121951,"preClose":0.082,"low":0.078,"week52Low":0.045,"pbRate":"11.70","psRate":"15.48","week52High":0.1,"institutionHeld":0,"latestPrice":0.078,"eps":-0.008993,"divideRate":0,"volume":118735,"delay":0,"ttmEps":-0.008993,"open":0.081,"prevYearClose":0.062,"prevWeekClose":0.067,"prevMonthClose":0.066,"prevQuarterClose":0.091,"fiveDayClose":0.067,"twentyDayClose":0.075,"sixtyDayClose":0.1},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FRE.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542136674","title":"Firebrick Pharma Says Phase 3 Data Back Efficacy, Safety of Nasal Spray; Shares Up 25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542136674","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542136674?lang=en_us&edition=fundamental","pubTime":"2025-06-10 12:37","pubTimestamp":1749530262,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  said Tuesday that the results of the first phase 3 clinical trial of its Nasodine nasal spray support the product's efficacy as a potential treatment for the common cold, especially when used early in the illness.Based on the results, Nasodine 0.5% povidone-iodine nasal spray effectively reduced cold severity, improving quality of life scores, and delivered a 40% greater benefit than saline when used within 24 hours of symptom onset, according to a Tuesday filing with the Australian bourse.Results, which were published in a peer-reviewed journal, also showed Nasodine to be safe and well-tolerated.The randomized, double-blind study was conducted on 260 adults who received either Nasodine or a matching saline nasal spray.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2542235634","title":"Firebrick Pharma Cancels Proposed Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2542235634","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542235634?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:50","pubTimestamp":1749513006,"startTime":"0","endTime":"0","summary":"Firebrick Pharma  decided not to proceed with a previously proposed share placement, following the company's request to be placed in a trading halt pending the announcement of the placement, according to a June 6 filing with the Australian bourse.On June 5, the company said the trading halt will remain in effect until the earlier of the start of normal trading on Tuesday or the release of the disclosure.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRE.AU","BK7096"],"gpt_icon":0},{"id":"2541924040","title":"BRIEF-Firebrick Pharma Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2541924040","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541924040?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:10","pubTimestamp":1749078613,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Seeks Trading HaltJune 5 (Reuters) - Firebrick Pharma Ltd FRE.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON SHARE PLACEMENTFurther company coverage: FRE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nFWN3S70Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","FRE.AU"],"gpt_icon":0},{"id":"2516816699","title":"BRIEF-Firebrick Pharma Secures Strategic Investment From Philippines Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2516816699","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516816699?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:21","pubTimestamp":1741051307,"startTime":"0","endTime":"0","summary":"BRIEF-Firebrick Pharma Secures Strategic Investment From Philippines PartnerMarch 4  - Firebrick Pharma Ltd FRE.AX:SECURES STRATEGIC INVESTMENT FROM PHILIPPINES PARTNERFIREBRICK SECURES A$1.1M STRATEGIC INVESTMENT FROM PHILIPPINES PARTNERFurther company coverage: FRE.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM0Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRE.AU","BK7096"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRE.AU\",market:\"AU\",,,undefined,":[]}}